Magnetic-based Immunoassay Detection
Current immunoassays diagnostics rely on optical detection technologies. Due to significant optical background in biological samples, these optical platforms are costly, time consuming and cumbersome due to the extensive sample washing and preparation needed. The QDTI imaging platform – using magnetic versus optical tags – enables an extremely simple, reliable and high-performance diagnostic capability. This all-magnetic detection approach is simpler, cheaper and highly flexible, allowing new biomarkers to be targeted quickly in key areas like neurology (such Alzheimer’s Disease and Parkinson’s), immuno-oncology and infectious disease. The QDTI magnetic detection approach holds tremendous potential to improve detection of critical biomarkers (e.g. proteins, nucleic acids, cells) with impacts on all phases of biomedical research and patient care.